OpenVSafe by OpenVAERS
Search V-safe

B48-23852-04555

2 vaccinations 9 coded responses 21 check-ins 9 free-text entries 1 call case
Sex
Male
Age at first dose
61-65
ZIP prefix
985 / WA
Registered
2021-02-27
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-02-25
    Dose 1 — Moderna
  2. 2021-02-27
    Registered in v-safe
  3. 2021-02-27
    Survey response — days 1–6 daily, dose 1
    MedDRA: Sinonasal obstruction — Feeling: Fair · Site: Pain · Headache
    Free text: Sinus/Nasal blockage
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-02-28
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Muscle or body aches
    Adult check-in
  5. 2021-03-01
    Survey response — days 1–6 daily, dose 1
    MedDRA: Sinus congestion, Sinus headache — Feeling: Fair · Site: Pain · Headache, Muscle or body aches · Be unable to do your normal daily activities
    Free text: Congested Sinuses, sinus headaches
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-03-02
    Survey response — days 1–6 daily, dose 1
    MedDRA: Sinus congestion — Feeling: Fair · Site: Pain · Headache, Muscle or body aches · Be unable to do your normal daily activities
    Free text: Sinus congestion
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-03-03
    Survey response — days 1–6 daily, dose 1
    MedDRA: Sinus congestion — Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Contined sinus congestion
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-03-04
    Health check-in — day 7, dose 1
    Feeling: Fair · Site: Pain · Headache, Muscle or body aches
    Adult check-in
  9. 2021-03-11
    Health check-in — day 14, dose 1
    Feeling: Fair
    Adult check-in
  10. 2021-03-18
    Survey response — day 21, dose 1
    MedDRA: Headache — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Headaches
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-03-24
    Dose 2 — Moderna
  12. 2021-03-24
    Health check-in — day 0, dose 2
    Feeling: Fair · Nausea, Abdominal pain · Be unable to do your normal daily activities
    Adult check-in
  13. 2021-03-25
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  14. 2021-03-26
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  15. 2021-03-27
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  16. 2021-03-28
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  17. 2021-03-30
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  18. 2021-03-31
    Health check-in — day 7, dose 2
    Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  19. 2021-04-07
    Survey response — day 14, dose 2
    MedDRA: Headache — Feeling: Good · Be unable to do your normal daily activities
    Free text: Continued low-grade headaches
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  20. 2021-04-14
    Survey response — day 21, dose 2
    MedDRA: Condition aggravated, Fatigue, Headache, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Continued low-grade headaches and fatigue. These symptoms have not yet stopped since vaccination nor have they subsided.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-04-21
    Survey response — day 28, dose 2
    MedDRA: Chest discomfort, Productive cough — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Low measured O² levels, ie 92%|93% up to 96%, coughing with phlegm, feeling of restricted breathing
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  22. 2021-04-28
    Survey response — day 35, dose 2
    MedDRA: Dysphagia, Dyspnoea, Office visit, Throat tightness, Wheezing — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Degrading breathing, for over a week, was only measuring 93% O² & verified by Primary Physician. Was wheezing & had tightness/restricted in my throat & was difficult to obtain sufficient breaths for over a week; was also difficult to swallow.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  23. 2021-04-28
    Report sent to call center — day 35, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  24. 2021-05-05
    Health check-in — day 42, dose 2
    Feeling: Fair
    Adult check-in
  25. 2021-06-23
    Health check-in — 3 months, dose 2
    Feeling: Fair
    Adult check-in
  26. 2022-04-10

Vaccinations

DoseDateManufacturerCo-administered
12021-02-25Moderna
22021-03-24Moderna

Call center

1 call center case

1 unsuccessful

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 4 — days 1–6 daily, dose 1

2021-02-27

Systemic reaction (other): Sinus/Nasal blockage

2021-03-01

Systemic reaction (other): Congested Sinuses, sinus headaches

2021-03-02

Systemic reaction (other): Sinus congestion

Release 5 — days 1–6 daily, dose 1

2021-03-03

Systemic reaction (other): Contined sinus congestion

Release 5 — day 21, dose 1

2021-03-18

Symptoms: Headaches

Release 7 — day 14, dose 2

2021-04-07

Symptoms: Continued low-grade headaches

Release 7 — day 21, dose 2

2021-04-14

Symptoms: Continued low-grade headaches and fatigue. These symptoms have not yet stopped since vaccination nor have they subsided.

Release 7 — day 28, dose 2

2021-04-21

Symptoms: Low measured O² levels, ie 92%|93% up to 96%, coughing with phlegm, feeling of restricted breathing

Release 8 — day 35, dose 2

2021-04-28

Symptoms: Degrading breathing, for over a week, was only measuring 93% O² & verified by Primary Physician. Was wheezing & had tightness/restricted in my throat & was difficult to obtain sufficient breaths for over a week; was also difficult to swallow.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDChest discomfort ✓ ✓ ✓
SDCondition aggravated ✓ ✓ ✓
SDDysphagia ✓ ✓ ✓
SDDyspnoea ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDHeadache ✓ ✓ ✓
SDOffice visit ✓ ✓ ✓
SDPre-existing disease ✓ ✓ ✓
SDProductive cough ✓ ✓ ✓
SDThroat tightness ✓ ✓ ✓
SDWheezing ✓ ✓ ✓
SROSinonasal obstruction ✓ ✓ ✓
SROSinus congestion ✓ ✓ ✓
SROSinus headache ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release